DAVID A STEVENSON, MD
Medical Practice at Pasteur Dr, Palo Alto, CA
License number
California 51508821205
Category
Medical Practice
Type
Pediatrics
License number
California 134246
Category
Medical Practice
Type
Clinical Genetics (M.D.)
License number
California 134246
Category
Medical Practice
Type
Pediatrics
Address
Address
300 Pasteur Dr #H315, Palo Alto, CA 94305
Phone
(650) 736-7696
Organization information
See more information about DAVID A STEVENSON at bizstanding.comDavid Stevenson MD
750 Welch Rd, Palo Alto, CA 94304
Industry:
Pediatrician
Phone:
(650) 723-5711 (Phone)
David Kendal Stevenson
Professional information
Dr. David K Stevenson, Palo Alto CA - MD (Doctor of Medicine)
Specialties:
Neonatal Medicine
Address:
Stanford University Medical Center NEO
750 Welch Rd, Palo Alto 94304
(650) 723-5711 (Phone)
750 Welch Rd, Palo Alto 94304
(650) 723-5711 (Phone)
Certifications:
Pediatrics, 1979, Perinatal Medicine & Neonatal Medicine, 2004
Awards:
Healthgrades Honor Roll
Languages:
English, Spanish
Hospitals:
Stanford University Medical Center NEO
750 Welch Rd, Palo Alto 94304
Stanford Hospital and Clinics
300 Pasteur Dr, Stanford 94305
750 Welch Rd, Palo Alto 94304
Stanford Hospital and Clinics
300 Pasteur Dr, Stanford 94305
Education:
Medical School
University Of Washington School Of Medicine
Graduated: 1975
Chldns Ortho Hospital Med Center
Graduated: 1976
University Of Washington
Graduated: 1977
Stanford University
Graduated: 1979
University Of Washington School Of Medicine
Graduated: 1975
Chldns Ortho Hospital Med Center
Graduated: 1976
University Of Washington
Graduated: 1977
Stanford University
Graduated: 1979
David Kendal Stevenson, Palo Alto CA
Specialties:
Pediatrics, Neonatal-Perinatal Medicine, Infectious Disease
Work:
Neonatal Intensive Care Unit
725 Welch Rd, Palo Alto, CA 94304 Stanford Hospital and Clinics
750 Welch Rd, Palo Alto, CA 94304
725 Welch Rd, Palo Alto, CA 94304 Stanford Hospital and Clinics
750 Welch Rd, Palo Alto, CA 94304
Education:
University of Washington (1975)
Neonatal Hemolysis Detection Using End-Tidal Breath Sampler And Analyzer Apparatus
US Patent:
5383469, Jan 24, 1995
Filed:
Oct 12, 1993
Appl. No.:
8/135142
Inventors:
Hendrik J. Vreman - Los Altos CA
David K. Stevenson - Palo Alto CA
David K. Stevenson - Palo Alto CA
Assignee:
Board of Trustees of the Leland Stanford Junior University - Palo Alto CA
International Classification:
A61B 508
US Classification:
128719
Abstract:
Apparatus for use in a hospital nursery, clinic, or physician's office for the sampling and analysis of neonatal end-tidal breath for carbon monoxide as an indication of hemolysis and subsequent infant jaundice includes a syringe and plunger for collecting end-tidal breath, a pump for supporting the syringe and including drive means for incrementally withdrawing the plunger and collecting end tidal breath, and a controller for the pump including a thermistor positionable to respond to the temperature of exhaled breath and generating an electrical signal in response to thermistor temperature. A rate detector receives the signal and determines exhalation rate. The signal is delayed in response to exhalation rate and then utilized to energize the pump in incrementally withdrawing the plunger in collecting end tidal breath. The pump can also be used in analysis equipment which extracts the end tidal breath sample with a sensor receiving the sample and determining carbon monoxide content. Alternatively, separate pumps can be employed for the sample collection and for the sample analysis.
Method To Prevent Neonatal Jaundice
US Patent:
4831024, May 16, 1989
Filed:
Oct 15, 1987
Appl. No.:
7/108743
Inventors:
Hendrik J. Vreman - Los Altos CA
David K. Stevenson - Palo Alto CA
David K. Stevenson - Palo Alto CA
Assignee:
The Board of Trustees of the Leland Stanford Junior University - Stanford CA
International Classification:
A61K 31555, A61K 4900
US Classification:
514185
Abstract:
Disclosed herein is an effective and safe method for preventing the onset of neonatal jaundice through the reduction of bilirubin production. This method can be applied to populations of infants based on mass screening procedures predictive of development of the disease. The most effective of these screening methods measures carbon monoxide production by the infants using a simple breath test.
Method To Prevent Neonatal Jaundice With Metalloporphyrin Compositions
US Patent:
5081115, Jan 14, 1992
Filed:
Mar 24, 1989
Appl. No.:
7/328205
Inventors:
Hendrik J. Vreman - Los Altos CA
David K. Stevenson - Palo Alto CA
David K. Stevenson - Palo Alto CA
Assignee:
The Board of Trustees of the Leland Stanford Junior University - Stanford CA
International Classification:
A61K 31555, C07D48722
US Classification:
514185
Abstract:
A formulation for administration of a metalloporphyrin compound useful in the treatment or prevention of jaundice is described. The formulation comprises the metalloporphyrin in admixture with an excipient which is a water-soluble organic amine, said composition having been neutralized to neutral pH. The formulation may advantageously contain a stabilizer, such as human serum albumin.